Detalhe da pesquisa
1.
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
Hematol Oncol
; 35(4): 528-535, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066928
2.
Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.
Br J Haematol
; 173(4): 573-81, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992145
3.
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Blood Adv
; 7(6): 963-970, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973200
4.
From Minimal Residual Disease to Maintenance Therapy: Optimizing Tools for Treatment of Mantle Cell Lymphoma.
Oncology (Williston Park)
; 30(4): 361-2, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083467
5.
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
J Geriatr Oncol
; 9(4): 321-328, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29673807
6.
Secondary acute myeloid leukemias arising from Philadelphia chromosome negative myeloproliferative neoplasms: pathogenesis, risk factors, and therapeutic strategies.
Curr Hematol Malig Rep
; 10(2): 112-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25893311